This grant funds state, territory, and city health departments to enhance viral hepatitis surveillance, outbreak response, testing, treatment, prevention, and elimination planning in high-impact settings.
Funder: Centers for Disease Control - NCHHSTP
Due Dates (Anticipated): February 2027 (projected)
Funding Amounts: Estimated total program funding: $450 million | ~60 awards expected | Award ceiling/floor not specified
Summary: Supports integrated viral hepatitis surveillance, testing, treatment, and prevention programs for state, territorial, and large city health departments.
Key Information: Forecasted opportunity—dates and requirements are subject to change.
This cooperative agreement supports state, territorial, and large city health departments in implementing integrated viral hepatitis surveillance, testing, treatment, and prevention programs. The initiative aims to improve outbreak response and surveillance for hepatitis A, B, and C (acute, chronic, and perinatal), enhance disease registries and data systems, expand hepatitis B and C testing and treatment in high-impact settings, and strengthen elimination planning and partnerships. The program is structured with two required components—Outbreak Response and Surveillance, and Planning, Partnerships, and Promotion—and two optional components—Testing, Treatment, and Prevention, and Perinatal Hepatitis C Program. The overarching goal is to advance viral hepatitis elimination efforts, improve surveillance and reporting, and expand access to prevention, diagnosis, and treatment.